NFR2/ABC transporter axis in drug resistance of breast cancer cells

[1]  M. Taheri,et al.  NRF2 signaling pathway: A comprehensive prognostic and gene expression profile analysis in breast cancer. , 2023, Pathology, research and practice.

[2]  M. feizi,et al.  VEGF-634G > C (rs2010963) Gene Polymorphism and High Risk of Breast Cancer in the Northwest of Iran , 2022, Indian Journal of Gynecologic Oncology.

[3]  R. Beňačka,et al.  Classic and New Markers in Diagnostics and Classification of Breast Cancer , 2022, Cancers.

[4]  A. Moosavi-Movahedi,et al.  Nrf2 Modulation in Breast Cancer , 2022, Biomedicines.

[5]  Shailja Sharma,et al.  ABC transporters in breast cancer: their roles in multidrug resistance and beyond , 2022, Journal of drug targeting.

[6]  R. Allikmets,et al.  The human ATP‐binding cassette (ABC) transporter superfamily , 2022, Human mutation.

[7]  Mohammad Valilo,et al.  The potential role of nicotine in breast cancer initiation, development, angiogenesis, invasion, metastasis, and resistance to therapy , 2022, Breast Cancer.

[8]  Y. Morine,et al.  Nrf2 signaling promotes cancer stemness, migration, and expression of ABC transporter genes in sorafenib-resistant hepatocellular carcinoma cells , 2021, PloS one.

[9]  Lili Tian,et al.  Clinically-Relevant ABC Transporter for Anti-Cancer Drug Resistance , 2021, Frontiers in Pharmacology.

[10]  L. Saso,et al.  Involvement of NRF2 in Breast Cancer and Possible Therapeutical Role of Polyphenols and Melatonin , 2021, Molecules.

[11]  Dong-Xu Liu,et al.  Pleiotropic Roles of ABC Transporters in Breast Cancer , 2021, International journal of molecular sciences.

[12]  R. Sheervalilou,et al.  The correlation between Twist 1 and 2 promoter methylation status and clinicopathologic characteristics of patients with breast cancer , 2020 .

[13]  G. Grech,et al.  A loop involving NRF2, miR‐29b‐1‐5p and AKT, regulates cell fate of MDA‐MB‐231 triple‐negative breast cancer cells , 2020, Journal of cellular physiology.

[14]  Yongdong Yi,et al.  Effect of miR-101 on proliferation and oxidative stress-induced apoptosis of breast cancer cells via Nrf2 signaling pathway. , 2019, European review for medical and pharmacological sciences.

[15]  Hong-Sheng Zhang,et al.  Nrf2 promotes breast cancer cell migration via up‐regulation of G6PD/HIF‐1α/Notch1 axis , 2019, Journal of cellular and molecular medicine.

[16]  Eric P. Winer,et al.  Breast Cancer Treatment: A Review , 2019, JAMA.

[17]  H. Zayed,et al.  Novel CD44-downstream signaling pathways mediating breast tumor invasion , 2018, International journal of biological sciences.

[18]  M. Gottesman,et al.  Revisiting the role of ABC transporters in multidrug-resistant cancer , 2018, Nature Reviews Cancer.

[19]  I. Endo,et al.  ABCC1-Exported Sphingosine-1-phosphate, Produced by Sphingosine Kinase 1, Shortens Survival of Mice and Patients with Breast Cancer , 2018, Molecular Cancer Research.

[20]  A. Yu,et al.  Bioengineered NRF2-siRNA Is Effective to Interfere with NRF2 Pathways and Improve Chemosensitivity of Human Cancer Cells , 2018, Drug Metabolism and Disposition.

[21]  Sang-Min Jeon,et al.  Dysregulation of NRF2 in Cancer: from Molecular Mechanisms to Therapeutic Opportunities , 2017, Biomolecules & therapeutics.

[22]  Fengxi Li,et al.  CDCA4, a downstream gene of the Nrf2 signaling pathway, regulates cell proliferation and apoptosis in the MCF-7/ADM human breast cancer cell line , 2017, Molecular medicine reports.

[23]  Kunming Zhao,et al.  iASPP Is an Antioxidative Factor and Drives Cancer Growth and Drug Resistance by Competing with Nrf2 for Keap1 Binding. , 2017, Cancer cell.

[24]  Wen Shi,et al.  Risk Factors and Preventions of Breast Cancer , 2017, International journal of biological sciences.

[25]  Ashutosh Kumar Singh,et al.  The see-saw of Keap1-Nrf2 pathway in cancer. , 2017, Critical reviews in oncology/hematology.

[26]  Guangji Wang,et al.  The down-regulation of SLC7A11 enhances ROS induced P-gp over-expression and drug resistance in MCF-7 breast cancer cells , 2017, Scientific Reports.

[27]  N. Samadi,et al.  Contradictory roles of Nrf2/Keap1 signaling pathway in cancer prevention/promotion and chemoresistance. , 2017, DNA repair.

[28]  Donna D. Zhang,et al.  ABCF2, an Nrf2 target gene, contributes to cisplatin resistance in ovarian cancer cells , 2017, Molecular carcinogenesis.

[29]  J. Bei,et al.  CDK20 interacts with KEAP1 to activate NRF2 and promotes radiochemoresistance in lung cancer cells , 2017, Oncogene.

[30]  Allimuthu T. Dharmaraja.  Role of Reactive Oxygen Species (ROS) in Therapeutics and Drug Resistance in Cancer and Bacteria. , 2017, Journal of medicinal chemistry.

[31]  Lei Wang,et al.  NRF2 promotes breast cancer cell proliferation and metastasis by increasing RhoA/ROCK pathway signal transduction , 2016, Oncotarget.

[32]  S. Giordano,et al.  The Dual Roles of NRF2 in Cancer. , 2016, Trends in molecular medicine.

[33]  S. Subramaniam,et al.  p62, Upregulated during Preneoplasia, Induces Hepatocellular Carcinogenesis by Maintaining Survival of Stressed HCC-Initiating Cells. , 2016, Cancer cell.

[34]  Hye-Youn Cho,et al.  Functional polymorphisms in Nrf2: implications for human disease. , 2015, Free radical biology & medicine.

[35]  A. Kong,et al.  Epigenetic regulation of Keap1-Nrf2 signaling. , 2015, Free radical biology & medicine.

[36]  C. Ricciardelli,et al.  The role of ABC transporters in ovarian cancer progression and chemoresistance. , 2015, Critical reviews in oncology/hematology.

[37]  Yi-fei Zhang,et al.  Promoter demethylation of nuclear factor-erythroid 2-related factor 2 gene in drug-resistant colon cancer cells. , 2015, Oncology letters.

[38]  In-geun Ryoo,et al.  Activation of NRF2 by p62 and proteasome reduction in sphere-forming breast carcinoma cells , 2015, Oncotarget.

[39]  In-geun Ryoo,et al.  The Sensitivity of Cancer Cells to Pheophorbide a-Based Photodynamic Therapy Is Enhanced by NRF2 Silencing , 2014, PloS one.

[40]  Shin-Young Ryu,et al.  Mitochondrial ion channels/transporters as sensors and regulators of cellular redox signaling. , 2014, Antioxidants & redox signaling.

[41]  H. Yamaguchi,et al.  Intestinal P-glycoprotein expression is multimodally regulated by intestinal ischemia-reperfusion. , 2014, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[42]  Ahmad Raza,et al.  Breast cancer: major risk factors and recent developments in treatment. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[43]  J. Hayes,et al.  The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. , 2014, Trends in biochemical sciences.

[44]  Takashi Suzuki,et al.  NRF2 immunolocalization in human breast cancer patients as a prognostic factor. , 2014, Endocrine-related cancer.

[45]  Antai Wang,et al.  Inhibition of NRF2 by PIK-75 augments sensitivity of pancreatic cancer cells to gemcitabine , 2013, International journal of oncology.

[46]  Donna D. Zhang,et al.  The emerging role of the Nrf2–Keap1 signaling pathway in cancer , 2013, Genes & development.

[47]  R. Gatenby,et al.  Beyond mammography: new frontiers in breast cancer screening. , 2013, The American journal of medicine.

[48]  Takafumi Suzuki,et al.  Toward clinical application of the Keap1-Nrf2 pathway. , 2013, Trends in pharmacological sciences.

[49]  Steven J. M. Jones,et al.  Comprehensive genomic characterization of squamous cell lung cancers , 2012, Nature.

[50]  G. Szakács,et al.  The controversial role of ABC transporters in clinical oncology. , 2011, Essays in biochemistry.

[51]  André F. Vieira,et al.  Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype , 2011, Journal of Clinical Pathology.

[52]  Lucia Anna Muscarella,et al.  Frequent epigenetics inactivation of KEAP1 gene in non-small cell lung cancer , 2011, Epigenetics.

[53]  Masayuki Yamamoto,et al.  Molecular mechanisms of the Keap1–Nrf2 pathway in stress response and cancer evolution , 2011, Genes to cells : devoted to molecular & cellular mechanisms.

[54]  Y. Hayashizaki,et al.  Correlation of axillary osmidrosis to a SNP in the ABCC11 gene determined by the Smart Amplification Process (SmartAmp) method. , 2010, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

[55]  Hailong Wu,et al.  Expression of ABCG2 (BCRP) Is Regulated by Nrf2 in Cancer Cells That Confers Side Population and Chemoresistance Phenotype , 2010, Molecular Cancer Therapeutics.

[56]  M. McMahon,et al.  p62/SQSTM1 Is a Target Gene for Transcription Factor NRF2 and Creates a Positive Feedback Loop by Inducing Antioxidant Response Element-driven Gene Transcription* , 2010, The Journal of Biological Chemistry.

[57]  Hailong Wu,et al.  Loss of Kelch-Like ECH-Associated Protein 1 Function in Prostate Cancer Cells Causes Chemoresistance and Radioresistance and Promotes Tumor Growth , 2010, Molecular Cancer Therapeutics.

[58]  N. Hamajima,et al.  Common Defects of ABCG2, a High-Capacity Urate Exporter, Cause Gout: A Function-Based Genetic Analysis in a Japanese Population , 2009, Science Translational Medicine.

[59]  N. Niikawa,et al.  A strong association of axillary osmidrosis with the wet earwax type determined by genotyping of the ABCC11 gene , 2009, BMC Genetics.

[60]  Zhong Chen,et al.  Suppression of ABCG2 inhibits cancer cell proliferation , 2009, International journal of cancer.

[61]  Hongqiao Zhang,et al.  Multidrug-resistant protein-3 gene regulation by the transcription factor Nrf2 in human bronchial epithelial and non-small-cell lung carcinoma. , 2009, Free radical biology & medicine.

[62]  C. B. Pickett,et al.  The Nrf2-Antioxidant Response Element Signaling Pathway and Its Activation by Oxidative Stress* , 2009, Journal of Biological Chemistry.

[63]  Tsutomu Ohta,et al.  Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy , 2008, Proceedings of the National Academy of Sciences.

[64]  Rajash Pallai,et al.  Dihydrodiol dehydrogenases regulate the generation of reactive oxygen species and the development of cisplatin resistance in human ovarian carcinoma cells , 2008, Cancer Chemotherapy and Pharmacology.

[65]  Se-Jin Kim,et al.  Suppression of Nrf2-driven heme oxygenase-1 enhances the chemosensitivity of lung cancer A549 cells toward cisplatin. , 2008, Lung cancer.

[66]  Jos Jonkers,et al.  Selective induction of chemotherapy resistance of mammary tumors in a conditional mouse model for hereditary breast cancer , 2007, Proceedings of the National Academy of Sciences.

[67]  R. Preston.  Epigenetic processes and cancer risk assessment. , 2007, Mutation research.

[68]  Xianglin Shi,et al.  Apigenin inhibits tumor angiogenesis through decreasing HIF-1alpha and VEGF expression. , 2006, Carcinogenesis.

[69]  J. Herman,et al.  Dysfunctional KEAP1–NRF2 Interaction in Non-Small-Cell Lung Cancer , 2006, PLoS medicine.

[70]  A. D’Andrea,et al.  DNA repair pathways in clinical practice: lessons from pediatric cancer susceptibility syndromes. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[71]  M. Gottesman,et al.  Targeting multidrug resistance in cancer , 2006, Nature Reviews Drug Discovery.

[72]  C. B. Pickett,et al.  The Carboxy-Terminal Neh3 Domain of Nrf2 Is Required for Transcriptional Activation , 2005, Molecular and Cellular Biology.

[73]  M. Gassmann,et al.  Regulation of the multidrug resistance transporter P‐glycoprotein in multicellular tumor spheroids by hypoxia‐inducible factor‐1 and reactive oxygen species , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[74]  A. Kong,et al.  Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes. , 2002, Current drug metabolism.

[75]  T. Hofer,et al.  Oxygen sensing, HIF-1α stabilization and potential therapeutic strategies , 2002, Pflügers Archiv - European Journal of Physiology.

[76]  E Yoshida,et al.  Two domains of Nrf2 cooperatively bind CBP, a CREB binding protein, and synergistically activate transcription , 2001, Genes to cells : devoted to molecular & cellular mechanisms.

[77]  S. Cole,et al.  Multidrug resistance proteins MRP3, MRP1, and MRP2 in lung cancer: correlation of protein levels with drug response and messenger RNA levels. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[78]  M. Schindl,et al.  Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. , 2000, Cancer research.

[79]  C. Wykoff,et al.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis , 1999, Nature.

[80]  K. Itoh,et al.  An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. , 1997, Biochemical and biophysical research communications.

[81]  Y. Kan,et al.  Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[82]  Daoqiang Zhang,et al.  Disordered signaling governing ferroportin transcription favors breast cancer growth. , 2015, Cellular signalling.

[83]  H. Figulla,et al.  Glycolytic pyruvate regulates P‐Glycoprotein expression in multicellular tumor spheroids via modulation of the intracellular redox state , 2010, Journal of cellular biochemistry.

[84]  M. Kuo.  Redox regulation of multidrug resistance in cancer chemotherapy: molecular mechanisms and therapeutic opportunities. , 2009, Antioxidants & redox signaling.

[85]  K. Nakata,et al.  Nuclear receptor-mediated transcriptional regulation in Phase I, II, and III xenobiotic metabolizing systems. , 2006, Drug metabolism and pharmacokinetics.

[86]  Karl Kuchler,et al.  ABC proteins : from bacteria to man , 2003 .

[87]  P. Borst,et al.  Mammalian ABC transporters in health and disease. , 2002, Annual review of biochemistry.